Macroaxis: Personalized Investing
Simple Personalized Investing

BAX COV BDX BCR Convertibles Healthcare Funds Macroaxis 20 Impulse 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for BAX

Baxter quote and profile

 
 Companies |  Insiders  | Dashboard  
     
71.51
  
STOCK
(0.64)  Macroaxis: -0.89 Down   0.89%  
Year To Date
48.9873.95
Last 1 Month(s)
68.5873.04
Trading Day 
71.3372.1
May 25 2013 

Diversification Suggestion

Use Baxter to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier
Analyze Baxter International Trend or Check current 30 days Baxter correlation with market (S&P 500)
1 Month Beta 0.75  
Highest Price:  
Lowest Price:  
73.04  
68.58  
May 21 2013 
May 07 2013 
As returns on market increase, Baxter returns are expected to increase less than the market. However during bear market, the loss on holding Baxter will be expected to be smaller as well.
Baxter International Inc Small BetaBaxter International Beta Legend
BAX United States NYSE
Baxter International Inc
Healthcare
Medical Instruments and Supplies
Benchmark S&P 500
http://www.baxter.com
Contact Number: 224. 948. 2000
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation42.71 B
Shares Outstanding541.95 M
Number of Shares Shorted5.88 M
Revenue14.25 B
 United States Russel   0.00 % No Change  
 
 United States Nasdaq   0.01 % Macroaxis: 0.01 Moved Down  
 
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 United States NYSE   0.25 % Macroaxis: 0.25 Moved Down  
 
 thisRed BAX BAX agains markets  0.89 % Macroaxis: 0.89 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Baxter Leadership

Robert Parkinson Chairman, CEO and Pres
Phillip Batchelor Corporate Vice President - Quality
Jean-Luc Butel Corporate VP and President of International
Norbert Riedel Corporate Vice President Chief Scientific Officer, Ph.D

Baxter Price and Market Media

The median price of Baxter for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 70.7 with a coefficient of variation of 1.82. The daily time series for the period is distributed with a sample standard deviation of 1.29, arithmetic mean of 70.86, and mean deviation of 1.02. The Stock received substential amount of media coverage during this period.
Baxter         SP 500
Price Growth (%)
 
1
BAXTER INTERNATIONAL INC. Baxter to Present at the Bank of A...04/26/2013Macroaxis: News
2
Baxter Alzheimer disease drug fails in latestage trial05/08/2013Macroaxis: Reuters News
3
BAXTER INTERNATIONAL INC. Baxter Receives Marketing Authoriz...05/22/2013Macroaxis: News
4
BAXTER INTERNATIONAL INC. Baxter to Present at the Goldman S...05/24/2013Macroaxis: News

Baxter Summary

Baxter International Inc [BAX] is traded on New York Stock Exchange in USA. It is located in Deerfield, IL and employs 51,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 39.18 B. Baxter International Inc runs under Healthcare sector within Medical Instruments and Supplies industry. This company has 541.95 M outstanding shares of which 5.88 M shares are currently shorted by investors with about 1.5 days to cover shorted positions.
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets solutions for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. more
Past Market
Over 30
Days
6
Out Of
100
 
Chance of
Less
Than
16 %
 
Follow Baxter with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Baxter to your reader
 

Baxter Research Report

Baxter vs. Covidien

Correlation analysis and fundamentals comparison between Baxter International and Covidien plc

Baxter Executives

Robert Hombach CFO and Corporate VP, MBA

Baxter Directors

Peter Hellman Independent Lead Director
Carole Shapazian Independent Director
James Gavin Independent Director
Gail Fosler Independent Director
Kornelis Storm Independent Director

Baxter Management

Mary Ladone IR Contact Officer

Baxter Fundamentals

Current Ratio vs Total Asset
Debt to Equity vs Shares Outstanding
Current Ratio vs Current Valuation
Price to Earning vs Shares Outstanding

Baxter vs Competition

Baxter vs. Covidien plc
Baxter vs. Becton Dickinson and Company
Baxter vs. CR Bard Inc
Baxter vs. CareFusion Corporation
Baxter vs. DENTSPLY International Inc
Baxter vs. The Cooper Companies Inc
Baxter vs. Mindray Medical International Limited
Baxter vs. Teleflex Incorporated
Baxter vs. West Pharmaceutical Services Inc

Baxter May 25 2013 Opportunity Range

Downside Deviation1.14
Information Ratio(0.01)
Maximum Drawdown5.06
Value At Risk(1.37)
Potential Upside2.6

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium